peptide hla Human leukocyte antigen (HLA) can recognize and bind foreign peptides - HLA peptideprediction progressively learns sequence patterns of specific peptide-HLA complexes Understanding Peptide-HLA Interactions: A Deep Dive into Immune Recognition

HLA-E The intricate dance between peptides and human leukocyte antigens (HLA) is fundamental to the adaptive immune system's ability to distinguish self from non-self. HLA molecules, also known as human major histocompatibility complex (MHC), are cell-surface proteins that play a critical role in presenting fragments of intracellular proteins, called peptides, to T cells. This presentation is the cornerstone of immune surveillance, alerting the body to the presence of pathogens or abnormal cells.

The study of peptide-HLA interactions, often abbreviated as pHLA, is a rapidly evolving field. Researchers are continuously developing sophisticated tools and methodologies to understand and predict these crucial binding events作者：RD Seidel·2021·被引用次数：10—We describe two immunotherapeutics platforms for selective delivery of costimulatory ligands andpeptide-HLA(pHLA) to AgS T cells.. For instance, advancements in computational approaches, such as the development of the SeqDA-HLA model, utilize language models and dual attention mechanisms for accurate peptide–HLA binding prediction. Similarly, the HLA3DB database provides comprehensive annotation of peptide/HLA complexes, enhancing our understanding of their structural properties. These computational tools are vital for screening potential peptide candidates for applications like personalized peptide vaccines, as highlighted by initiatives like HLAEquity, which examines biases in pan-allele peptide-HLA prediction.

HLA class I molecules, in particular, are known to bind peptides ranging from 8 to 15 amino acids in length. These peptides are typically derived from intracellular proteins that have undergone proteasomal degradation.Peptide ready MHC molecules comprising human HLA alleles and B2M, which can be readily tetramerized and loaded with peptides of choice in a high-throughput ... The ability of HLA to recognize and bind foreign peptides is essential for initiating an immune responseHLA class I alleles are associated with peptide binding ... - PMC. This process is vital for T cell recognition, especially the presentation of intracellular peptides to CD8+ T cells, a key mechanism for clearing infected or cancerous cells. Even HLA low expression variants have demonstrated the capacity to present peptides, indicating their functional activity in immune processes. Furthermore, HLA class I presentation of pathogen-derived peptide ligands is crucial for the recognition of infected cells by T cells, as seen in the context of pathogens like *Toxoplasma gondii*.

The binding affinity and stability of a peptide:HLA (pHLA) complex are critical for eliciting a durable immune response. When a peptide binds to an HLA molecule with adequate affinity and stability, it can effectively signal to T cells. The diversity of HLA allotypes contributes to a vast repertoire of presented peptides, influencing the recognition of various antigens. Research has shown that each HLA allele is associated with a different number/proportion of peptides that bind below a certain affinity threshold, underscoring the specificity of these interactions.作者：G Kim·2025—Overall, SeqDA-HLA serves as a powerful and interpretable tool forpeptide–HLA binding prediction, with potential applications in epitope-based ...

Beyond HLA class I, HLA class II molecules also play a significant role in immunity, albeit by presenting peptides derived from extracellular sources. Understanding the differences between HLA class I vs 2 is crucial for a complete picture of antigen presentation. While HLA class I molecules primarily present endogenous peptides to CD8+ T cells, HLA class II molecules present exogenous peptides to CD4+ T cells, a distinction that impacts the type of immune response generatedThe pockets guide to HLA class I molecules - PMC.

The IPD-IMGT/HLA Database serves as a vital resource, providing specialist data for sequences of the human MHC, including official sequences. This database is instrumental for researchers studying HLA structure and function. The polymorphic nature of HLA alleles leads to a wide array of presented peptides, and understanding these specificities is key to developing effective immunotherapies. For instance, peptide-HLA-based immunotherapeutics platforms are being developed for selective delivery of costimulatory ligands and pHLA to antigen-specific T cells作者：JR Hopkins·2022·被引用次数：18—This review explores how these recent findingsredefine the rules for peptide presentation by HLA-I moleculesand extend our understanding of the molecular ....

The study of peptide-HLA binding is not without its complexities. Researchers are exploring unconventional modes of peptide–HLA-I presentation that can alter immune responses. Tools like CapHLA aim to predict peptide presentation by HLA-I molecules, while other methods are focused on predicting the binding of peptides to HLA (pHLA), which is crucial for screening effective immune therapy antigen targets.作者：M Rasmussen·2014·被引用次数：106—Peptidebinding is a fundamental requirement for the proper folding, expression, and function of classicalHLAmolecules. Obviously, the final outcome depends ... The development of peptide-ready MHC molecules, such as those comprising human HLA alleles and B2M, facilitates high-throughput peptide loading and analysis.

In summary, the interaction between peptides and HLA molecules is a fundamental aspect of human immunology. Continued research into peptide-HLA binding prediction, the structural nuances of HLA molecules, and the diverse peptide repertoires they present is essential for advancing our understanding of immune function and developing novel therapeutic strategies.What is HLA? HLA Basics, Typing & Matching​ Overview​ | NMDP​ The field continues to explore new frontiers, including the role of HLA-E molecules as protective immune proteins and the potential of specific peptide sequences, such as the Antigen Peptide MAGE-A1 HLA-A*0101, in stimulating antigen-specific T cells. Ultimately, a deeper comprehension of these molecular interactions will pave the way for more effective treatments for a range of diseases.